Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/13/25 19:48 | 8/13/25 | MXCT | Health | Biolab | Commercial Physical & Biologi | Swirsky Douglas J | MD | O | CFO | 1 | P | 65 | 1.29 | 0 | 50 | 45 | 162 | D | ||||||||||||||
8/13/25 19:47 | 6/7/24 | MXCT | Health | Biolab | Commercial Physical & Biologi | Masoud Maher | MD | DO | P,CEO | 2 | P.m | 592 | 3.38 | 0 | 175 | 175 | D | |||||||||||||||
8/13/25 19:47 | 8/13/25 | MXCT | Health | Biolab | Commercial Physical & Biologi | Erck Stanley C | MD | D | 1 | P | 137 | 1.37 | 0 | 100 | 34 | 398 | D | |||||||||||||||
8/13/25 19:46 | 8/13/25 | MXCT | Health | BioPrd | Biological Products, (No Diag | Douglas Richard | MD | D | 1 | P | 111 | 1.39 | 0 | 80 | 53 | 231 | D | |||||||||||||||
8/13/25 19:45 | 8/13/25 | MXCT | Health | Biolab | Commercial Physical & Biologi | Brooke William W | MD | D | 1 | P | 65 | 1.29 | 0 | 50 | 50 | 151 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |